• Home
  • Pleiotropic MLLT10 variation confers risk of meningioma and estrogen-mediated cancers.

Pleiotropic MLLT10 variation confers risk of meningioma and estrogen-mediated cancers.

Author List
Walsh KM, Zhang C, Calvocoressi L, Hansen HM, Berchuck A, Schildkraut JM, Bondy ML, Wrensch M, Wiemels JL, Claus EB
Publication
Neuro-oncology advances
Publication ID (Profile URL)
https://researcherprofiles.org/profile/305034431
Publication Year
2022
PubMed ID
35702670
Publication Title
Walsh KM, Zhang C, Calvocoressi L, Hansen HM, Berchuck A, Schildkraut JM, Bondy ML, Wrensch M, Wiemels JL, Claus EB. Pleiotropic MLLT10 variation confers risk of meningioma and estrogen-mediated cancers. Neurooncol Adv. 2022 Jan-Dec; 4(1):vdac044.